Commit and Aortic bruit - a phase IV clinical study of FDA data
Summary:
We study 5,005 people who take Commit (nicotine polacrilex) or have Aortic bruit. No report of Aortic bruit is found in people who take Commit.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Commit?
Commit has active ingredients of nicotine polacrilex. eHealthMe is studying from 4,842 Commit users. Check the latest studies of Commit.
What is Aortic Bruit?
Aortic bruit (unusual sound that blood makes when it rushes past an obstruction in aortic artery) is found to be associated with 37 drugs and 94 conditions by eHealthMe. Check the latest studies of Aortic bruit.
No report is found.
Do you take Commit and have Aortic bruit?
- Check whether Aortic bruit is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Commit:
- Commit (4,842 reports)
Aortic bruit treatments and more:
- Aortic bruit (163 reports)
How severe was Aortic bruit and when was it recovered:
Expand to all the drugs that have ingredients of nicotine polacrilex:
Browse all side effects of Commit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Aortic bruit:
Browse all the conditions that are associated with Aortic bruit:
How the study uses the data?
The study uses data from the FDA. It is based on nicotine polacrilex (the active ingredients of Commit) and Commit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Fexofenadine Hydrochloride cause Heart Rate Irregular? - 8 seconds ago
- Drug interactions of Dupixent and Cevimeline Hydrochloride - 12 seconds ago
- Drug interactions of Promethazine and Actrapid - 23 seconds ago
- Primary Myelofibrosis and Acute Graft Versus Host Disease - 25 seconds ago
- Prednisone and Tagamet drug interactions for men aged 50-59 - 28 seconds ago
- Could Bioflavonoids cause High Blood Pressure? - 36 seconds ago
- Indigestion and Retinal Detachment - 39 seconds ago
- Could Daliresp cause Panic Disorder? - 40 seconds ago
- Could Thalidomide cause Pneumonia Aspiration? - 41 seconds ago
- Could Aromasin cause Red Cell Distribution Width Increased? - 49 seconds ago